VIQ Announces Conference Call to Discuss Third Quarter Results
Nov 14, 2017 21:01 pm UTC| Business
TORONTO, Ontario, Nov. 14, 2017 -- VIQ Solutions Inc. (“VIQ” or the “Company”) (TSX Venture:VQS), a global expert in secure digital media technology and services, announced today that the Company will hold a conference...
Invuity to Present at Upcoming Investor Conferences
Nov 14, 2017 21:01 pm UTC| Business
SAN FRANCISCO, Nov. 14, 2017 -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that company management is scheduled to attend the following upcoming...
Molecular Templates, Inc. Reports Third Quarter 2017 Financial Results
Nov 14, 2017 21:01 pm UTC| Business
Completed Merger with Threshold Pharmaceuticals in August Recent Equity Financings of $60 Million Provide Cash Runway into late 2019 MT-3724 Advancing in Clinical Trials with New Data Expected in 1H18 AUSTIN, Texas,...
Rex Energy Reports Third Quarter 2017 Financial and Operational Results
Nov 14, 2017 21:01 pm UTC| Business
STATE COLLEGE, Pa., Nov. 14, 2017 -- Rex Energy Corporation (Nasdaq:REXX) today announced its third quarter 2017 financial and operational results. In Butler Legacy, placed four-well Wilson pad into sales; initial...
Nov 14, 2017 21:01 pm UTC| Business
WILMINGTON, Del., Nov. 14, 2017 -- Acorn Energy, Inc. (OTCQB:ACFN), a provider of Internet of Things (IoT) remote monitoring and control systems and services, announced results for its third quarter ended September 30,...
ParkerVision Reports Third Quarter 2017 Results
Nov 14, 2017 21:01 pm UTC| Business
JACKSONVILLE, Fla., Nov. 14, 2017 -- ParkerVision, Inc. (NASDAQ:PRKR), a developer and marketer of semiconductor technology solutions for wireless applications, today announced results for the three and nine months...
Aptose Reports Results for the Third Quarter Ended September 30, 2017
Nov 14, 2017 21:00 pm UTC| Business
SAN DIEGO and TORONTO, Nov. 14, 2017 -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying...